Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BON | Ann: Month end units on issue | 06/08/25 | 0 | 69 | |||
|
|||||||
BON | Ann: Month end units on issue | 04/07/25 | 0 | 90 | |||
|
|||||||
BON | Ann: DRP Distribution Announcement June 2025 | 03/07/25 | 0 | 80 | |||
|
|||||||
BON | Ann: Distribution Announcement June 2025 | 27/06/25 | 0 | 88 | |||
|
|||||||
BON | Ann: Distribution Estimate | 18/06/25 | 0 | 102 | |||
|
|||||||
BON | Ann: Month end units on issue | 05/06/25 | 0 | 111 | |||
|
|||||||
BON | Ann: Supplementary Product Disclosure Statement | 19/05/25 | 0 | 175 | |||
|
|||||||
BON | Ann: Management Fee Reduction & Benchmark Index Change | 19/05/25 | 0 | 128 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |